6 assets in Drug-Induced Liver Injury

Therapeutic assets addressing Drug-Induced Liver Injury, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Levocarnitine Drug-Induced Liver Injury	Children's Hospital of Orange County	Early P1	C (39)
mt2004 Drug-Induced Liver Injury	Xi'An Aolitai Pharmaceutical Technology Co Ltd	P2	NR ()
Silymarin Drug-Induced Liver Injury	Tanta University	P2/3	NR ()